Compare studies and check their requirements with the research team.
This study is active but not recruiting in the United States. It is testing endoxifen for Bipolarity.
In United StatesThis study is completed in the United States, in France, in Canada, .... It is testing Extended-release Guanfacine Hydrochloride for ADHD.
In United StatesThis study is completed in the United States. It is testing galantamine for Bipolarity.
In United StatesThis study is completed in the United States and in India. It is testing iloperidone Compared With Placebo and Active Control for schizophrenia.
In United StatesThis study is completed in the United States. It is testing Lisdexamfetamine Dimesylate (LDX) for ADHD.
In United StatesThis study was terminated in the United States. It is testing Lu AA39959 for depression in bipolarity.
In United StatesThis study is completed in the United States. It is testing Methylphenidate HCl ER Capsules for ADHD.
In United StatesThis study was terminated in the United States. It is testing MK-1942 When Added to Stable Antidepressant Therapy for treatment-resistant depression.
In United StatesThis study is completed in the United States. It is testing NFC-1 for ADHD.
In United StatesThis study is completed in the United States. It is testing NS2359 for ADHD.
In United StatesThis study is completed in the United States. It is testing Once-Daily Atomoxetine Hydrochloride for ADHD.
In United StatesThis study is completed in the United States, in Canada, in Bulgaria, .... It is testing pimavanserin for schizophrenia.
In United StatesHopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.